WallStSmart

Medline Inc. Class A Common Stock (MDLN)vsMerit Medical Systems Inc (MMSI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medline Inc. Class A Common Stock generates 1789% more annual revenue ($29.14B vs $1.54B). MMSI leads profitability with a 9.0% profit margin vs 3.3%. MMSI trades at a lower P/E of 28.7x. MMSI earns a higher WallStSmart Score of 61/100 (C+).

MDLN

Buy

52

out of 100

Grade: C-

Growth: 7.3Profit: 5.5Value: 4.7Quality: 6.5
Piotroski: 4/9Altman Z: 1.79

MMSI

Buy

61

out of 100

Grade: C+

Growth: 7.3Profit: 6.0Value: 4.7Quality: 7.5
Piotroski: 4/9Altman Z: 2.44
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MDLN.

MMSISignificantly Overvalued (-49.5%)

Margin of Safety

-49.5%

Fair Value

$54.37

Current Price

$64.48

$10.11 premium

UndervaluedFair: $54.37Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDLN3 strengths · Avg: 9.0/10
EPS GrowthGrowth
1258.0%10/10

Earnings expanding 1258.0% YoY

Market CapQuality
$65.23B9/10

Large-cap with strong market position

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

MMSI2 strengths · Avg: 8.0/10
Price/BookValuation
2.4x8/10

Reasonable price relative to book value

EPS GrowthGrowth
38.8%8/10

Earnings expanding 38.8% YoY

Areas to Watch

MDLN4 concerns · Avg: 3.5/10
P/E RatioValuation
32.1x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.794/10

Distress zone — elevated risk

Profit MarginProfitability
3.3%3/10

3.3% margin — thin

Debt/EquityHealth
1.123/10

Elevated debt levels

MMSI1 concerns · Avg: 4.0/10
P/E RatioValuation
28.7x4/10

Moderate valuation

Comparative Analysis Report

WallStSmart Research

Bull Case : MDLN

The strongest argument for MDLN centers on EPS Growth, Market Cap, Price/Book. Revenue growth of 10.7% demonstrates continued momentum.

Bull Case : MMSI

The strongest argument for MMSI centers on Price/Book, EPS Growth. PEG of 1.41 suggests the stock is reasonably priced for its growth.

Bear Case : MDLN

The primary concerns for MDLN are P/E Ratio, Altman Z-Score, Profit Margin. Thin 3.3% margins leave little buffer for downturns.

Bear Case : MMSI

The primary concerns for MMSI are P/E Ratio.

Key Dynamics to Monitor

MDLN is growing revenue faster at 10.7% — sustainability is the question.

MDLN generates stronger free cash flow (316M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MMSI scores higher overall (61/100 vs 52/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medline Inc. Class A Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Visit Website →

Merit Medical Systems Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, intensive care, and endoscopy. The company is headquartered in South Jordan, Utah.

Want to dig deeper into these stocks?